Pesquisadores da ENSP participam de painel sobre febre amarela
Publicado em:27/01/2017
Em cooperação com a Secretaria Estadual de Saúde do Rio de Janeiro, a Fiocruz realizará, no dia 31/1, terça-feira, um painel sobre a febre amarela e o monitoramento de primatas em território fluminense por conta do recente surto da doença em estados vizinhos. O evento, que visa identificar sistemas de alerta para monitorar a entrada da doença no Estado do Rio de Janeiro, tem como objetivos apresentar o cenário do problema no país, a estrutura para o enfrentamento de surtos, o fluxo para a notificação de casos em macacos e humanos. O vice-diretor de Ambulatórios e Laboratórios da ENSP, Marco Menezes, e a pesquisadora e docente da Escola Telma Abdalla farão parte do encontro. Os interessados devem se inscrever para participar, e as inscrições podem ser feitas aqui.
Além de Menezes e Telma, a pesquisadora da ENSP e coordenadora do Centro de Informação em Saúde Silvestre do Programa Institucional Biodiversidade & Saúde da Fiocruz, Marcia Chame, apresentará o Siss-Geo - ferramenta de monitoramento de epizootias (enfermidades contagiosas que atacam um número inusitado de animais ao mesmo tempo e na mesma região e se propagam com rapidez).
O painel, que tratará do vírus, vetores, macacos, da doença e da vacina, discutirá propostas para o fortalecimento da integração entre os diversos setores e alinhará ações para a detecção precoce de macacos mortos e intercâmbio de informações. O evento é destinado a gestores de unidades de conservação, guarda-parques, montanhistas, guias de ecoturismo, comunidades rurais do entorno de áreas naturais, pesquisadores em campo e demais interessados e ocorrerá no auditório do Museu da Vida, campus da Fiocruz, em Manguinhos, das 8h30 às 15h.
Programação
8h30 – Credenciamento e café de boas-vindas
9h – Mesa de Abertura
Nísia Trindade - Presidente da Fiocruz
Márcio Henrique de Oliveira Garcia - Coordenador Geral de Vigilância e Resposta / Departamento de Vigilância das Doenças Transmissíveis/SVS/MS
Alexandre Chieppe - Subsecretário de Vigilância em Saúde da SES-RJ
Marco Menezes - Vice-Presidente de Ambiente, Atenção e Promoção da Saúde
9h30 – O Cenário da Febre Amarela no Brasil
Renato Vieira Alves - Unidade Técnica de Vigilância das Doenças de Transmissão Vetorial / Coordenação Geral de Doenças Transmissíveis / Departamento de Vigilância das Doenças Transmissíveis/SVS/MS
10h20 – Mesa-redonda: A febre amarela
Guilherme Franco Netto (VPAAPS/Fiocruz) - moderador
Ana Bispo (IOC/Fiocruz) - O vírus e o diagnóstico laboratorial
Goreti Rosa Freitas (IOC/Fiocruz) - Os vetores
Alcides Pissinatti (CPRJ/ SEA) - Os macacos
Juliana Arruda de Matos (INI/Fiocruz) - A doença e a vacina
Telma Abdalla (ENSP/Fiocruz) - Coleta de primatas: manejo de risco no campo
11h40 – Procedimentos da vigilância de epizootias no Rio de Janeiro
Mario Sérgio Ribeiro (SES/RJ) - Superintendente de Vigilância Epidemiológica e Ambiental
12h30 – Almoço
13h30 – Monitoramento de epizootias com a participação da sociedade
Marcia Chame (PIBSS/Fiocruz) - O Sistema de Informação em Saúde Silvestre (SISS-Geo)
14h – Debate – Propostas para o monitoramento da febre amarela em primatas no Rio de Janeiro
15h – Encerramento
Pesquisadores da ENSP participam de painel sobre febre amarela
2 comentáriosEDUARDO S. PONCE MARANHÃO
29/01/2017 17:21
FEBRE AMARELA - BRASIL (18), OMS/WHO
************************************
Uma mensagem / Una mensaje / de ProMED-PORT
ProMED-mail e um programa da / es un programa de la
International Society for Infectious Diseases
Data: Sábado, 28 de janeiro de 2017
Fonte: OMS/WHO [27/01/2017] [editado]
Yellow fever - Brazil
-------------------------
On 24 January 2017, Brazil's International Health Regulations (IHR)
National Focal Point (NFP) provided the Pan American Health
Organization/World Health Organization (PAHO/WHO) with an update on
the yellow fever situation. The geographical distribution of confirmed
yellow fever human cases is expanding and includes, in addition to
Minas Gerais State, the States of Espírito Santo and São Paulo. In
addition, Bahia State reported 6 yellow fever human cases under
investigation.
Espírito Santo State, an area that was previously not considered at
risk for yellow fever, confirmed its first autochthonous human case of
yellow fever since 1940. The case is a 44-year-old male from the
municipality of Ibatiba.
São Paulo State, reported three laboratory-confirmed cases of human
yellow fever, all of whom died.
In Minas Gerais State, as of 24 January, a total of 404 cases (66
confirmed, 337 suspected and 1 discarded), including 84 deaths (37
among confirmed cases and 47 among suspected with a case fatality rate
of 56% and 14%, respectively) were reported. The total number of
suspected and confirmed yellow fever cases reported is the highest
reported nationwide since 2000.
Among the 66 confirmed cases from Minas Gerais State, 88% are male and
45% have not been vaccinated against yellow fever (the vaccination
status of the remaining 55% is unknown or not available).
Additionally, a large number of epizootics among non-human primates
(NHP) were reported in the States of São Paulo (247 epizootics,
including 3 confirmed for yellow fever) and Espírito Santo (367
epizootics). In Espírito Santo State, epizootics have been confirmed
for yellow fever in Irupia and Colatina municipalities.
Public health response
----
Brazilian health authorities, at the federal, state, and municipal
levels, are implementing several measures to respond to the outbreak,
including:
In addition to the 650,000 doses of yellow fever vaccine distributed
across the country as part of the routine supply of the National
Vaccination Calendar in January 2017, the Ministry of Health of Brazil
has sent 4.2 million doses of yellow fever vaccines to the States of
Bahia (400,000), Espírito Santo (1 million), Minas Gerais (2.4
million), and Rio de Janeiro (350,000).
Vector control activities to eliminate Aedes aegypti breeding sites in
affected municipalities have started.
A Situation Room has been established in the affected states and at
the national level.
A web portal was launched by the Ministry of Health to inform the
public about the situation and provide guidance.
WHO risk assessment
----
The increase in the number of yellow fever cases in the State of Minas
Gerais, the confirmation of cases in two new states, alongside the
occurrence of epizootics in the states reporting human cases,
highlights the geographical spread of the outbreak to new areas.
At this stage, there is no evidence that Aedes aegypti is implicated
in the transmission in the current outbreak. However, the risk of
urban transmission of yellow fever cannot be ruled out.
It is expected that additional cases will be detected in other states
in Brazil given the internal movement of people and infected monkeys
and the low level of vaccination coverage in areas that were
previously not considered to be at risk for yellow fever transmission.
There is also a risk that infected individuals may travel to areas,
within or outside of Brazil, where the Aedes mosquitoes are present
and initiate local cycles of human-to-human transmission. At present,
there are no yellow fever cases reported in the neighbouring countries
associated with this current outbreak.
The current outbreak and upsurge of yellow fever activity in Brazil
extends beyond those areas considered to be at risk for yellow fever
transmission as presented in the WHO publication "International Travel
and Health, 2016", while national authorities are taking appropriate
steps to contain this epidemic, yellow fever vaccination
recommendations for travellers need to be updated.
The newly defined areas at risk for yellow fever transmission in
Brazil present the following differences with from the 2013 risk
assessment (see "Areas at risk for yellow fever transmission in
Brazil, 2013-2017" below):
- Bahia State: extension of the areas at risk for yellow fever
transmission with the inclusion of the following municipalities in the
south and south-west of the States: Alcobasa; Belmonte; Canavieiras;
Caravelas; Ilheus; Itacare; Mucuri; Nova Visosa; Porto Seguro; Prado;
Santa Cruz Cabralia; Una; Urusuca; Almadina; Anage; Arataca; Barra do
Chosa; Barro Preto; Belo Campo; Buerarema; Caatiba; Camacan; Candido
Sales; Coaraci; CondeUba; Cordeiros; Encruzilhada; Eunapolis; Firmino
Alves; Floresta Azul; Guaratinga; Ibicarai; Ibicui; Ibirapua; Itabela;
Itabuna; Itagimirim; Itaju do Colonia; Itajuipe; Itamaraju; Itambe;
Itanhem; Itape; Itapebi; Itapetinga; Itapitanga; Itarantim; Itororo;
Jucurusu; Jussari; Lajedao; Macarani; Maiquinique; Mascote; Medeiros
Neto; Nova Canaa; Pau Brasil; Piripa; Planalto; Posoes; Potiragua;
Ribeirao do Largo; Santa Cruz da Vitoria; Santa Luzia; São Jose da
Vitoria; Teixeira de Freitas; Tremedal; Vereda; Vitoria da Conquista;
- Espírito Santo State: at risk for yellow fever transmission with
the exception of the urban area of Vitoria;
- Rio de Janeiro State: at risk for yellow fever transmission in the
following northern municipalities bordering Minas Gerais and Espírito
Santo States: Bom Jesus do Itabapoana; Cambuci; Cardoso Moreira;
Italva; Itaperuna; Laje do Muriae; Miracema; Natividade; Porciuncula;
Santo Antonio de Padua; São Fidelis; São Jose de Uba; Varre-Sai;
Campos dos Goytacazes; São Francisco de Itabapoa; São João da
Barra.
This determination of new areas deemed to be at risk for yellow fever
transmission represents the first preliminary and precautionary step
of a dynamic risk assessment process.
WHO advice
----
Advice to travellers planning to visit areas at risk for yellow fever
transmission in Brazil includes vaccination against yellow fever at
least 10 days prior to the travel; observation of measures to avoid
mosquito bites, awareness of symptoms and signs of yellow fever,
promotion of health care seeking behavior while traveling and upon
return from an area at risk for yellow fever transmission, especially
to a country where the competent vector for yellow fever transmission
is present.
As per Annex 7 of the IHR a single dose of yellow fever vaccine is
sufficient to confer sustained immunity and life-long protection
against yellow fever disease. Booster doses of yellow fever vaccine
are not needed. If, on medical ground, a traveler cannot be vaccinated
against yellow fever, this must be certified by the relevant
authorities as per Annex 6 and Annex 7 of the IHR.
The WHO Secretariat does not recommend restriction of travel and trade
with Brazil on the basis of the information currently available on
this event.
[Veja o mapa acessando:
]
--
Comunicado por: ProMED-PORT
EDUARDO S. PONCE MARANHÃO
29/01/2017 17:20
FEBRE AMARELA - BRASIL (18), OMS/WHO
************************************
Uma mensagem / Una mensaje / de ProMED-PORT
ProMED-mail e um programa da / es un programa de la
International Society for Infectious Diseases
Data: Sábado, 28 de janeiro de 2017
Fonte: OMS/WHO [27/01/2017] [editado]
Yellow fever - Brazil
-------------------------
On 24 January 2017, Brazil's International Health Regulations (IHR)
National Focal Point (NFP) provided the Pan American Health
Organization/World Health Organization (PAHO/WHO) with an update on
the yellow fever situation. The geographical distribution of confirmed
yellow fever human cases is expanding and includes, in addition to
Minas Gerais State, the States of Espírito Santo and São Paulo. In
addition, Bahia State reported 6 yellow fever human cases under
investigation.
Espírito Santo State, an area that was previously not considered at
risk for yellow fever, confirmed its first autochthonous human case of
yellow fever since 1940. The case is a 44-year-old male from the
municipality of Ibatiba.
São Paulo State, reported three laboratory-confirmed cases of human
yellow fever, all of whom died.
In Minas Gerais State, as of 24 January, a total of 404 cases (66
confirmed, 337 suspected and 1 discarded), including 84 deaths (37
among confirmed cases and 47 among suspected with a case fatality rate
of 56% and 14%, respectively) were reported. The total number of
suspected and confirmed yellow fever cases reported is the highest
reported nationwide since 2000.
Among the 66 confirmed cases from Minas Gerais State, 88% are male and
45% have not been vaccinated against yellow fever (the vaccination
status of the remaining 55% is unknown or not available).
Additionally, a large number of epizootics among non-human primates
(NHP) were reported in the States of São Paulo (247 epizootics,
including 3 confirmed for yellow fever) and Espírito Santo (367
epizootics). In Espírito Santo State, epizootics have been confirmed
for yellow fever in Irupia and Colatina municipalities.
Public health response
----
Brazilian health authorities, at the federal, state, and municipal
levels, are implementing several measures to respond to the outbreak,
including:
In addition to the 650,000 doses of yellow fever vaccine distributed
across the country as part of the routine supply of the National
Vaccination Calendar in January 2017, the Ministry of Health of Brazil
has sent 4.2 million doses of yellow fever vaccines to the States of
Bahia (400,000), Espírito Santo (1 million), Minas Gerais (2.4
million), and Rio de Janeiro (350,000).
Vector control activities to eliminate Aedes aegypti breeding sites in
affected municipalities have started.
A Situation Room has been established in the affected states and at
the national level.
A web portal was launched by the Ministry of Health to inform the
public about the situation and provide guidance.
WHO risk assessment
----
The increase in the number of yellow fever cases in the State of Minas
Gerais, the confirmation of cases in two new states, alongside the
occurrence of epizootics in the states reporting human cases,
highlights the geographical spread of the outbreak to new areas.
At this stage, there is no evidence that Aedes aegypti is implicated
in the transmission in the current outbreak. However, the risk of
urban transmission of yellow fever cannot be ruled out.
It is expected that additional cases will be detected in other states
in Brazil given the internal movement of people and infected monkeys
and the low level of vaccination coverage in areas that were
previously not considered to be at risk for yellow fever transmission.
There is also a risk that infected individuals may travel to areas,
within or outside of Brazil, where the Aedes mosquitoes are present
and initiate local cycles of human-to-human transmission. At present,
there are no yellow fever cases reported in the neighbouring countries
associated with this current outbreak.
The current outbreak and upsurge of yellow fever activity in Brazil
extends beyond those areas considered to be at risk for yellow fever
transmission as presented in the WHO publication "International Travel
and Health, 2016", while national authorities are taking appropriate
steps to contain this epidemic, yellow fever vaccination
recommendations for travellers need to be updated.
The newly defined areas at risk for yellow fever transmission in
Brazil present the following differences with from the 2013 risk
assessment (see "Areas at risk for yellow fever transmission in
Brazil, 2013-2017" below):
- Bahia State: extension of the areas at risk for yellow fever
transmission with the inclusion of the following municipalities in the
south and south-west of the States: Alcobasa; Belmonte; Canavieiras;
Caravelas; Ilheus; Itacare; Mucuri; Nova Visosa; Porto Seguro; Prado;
Santa Cruz Cabralia; Una; Urusuca; Almadina; Anage; Arataca; Barra do
Chosa; Barro Preto; Belo Campo; Buerarema; Caatiba; Camacan; Candido
Sales; Coaraci; CondeUba; Cordeiros; Encruzilhada; Eunapolis; Firmino
Alves; Floresta Azul; Guaratinga; Ibicarai; Ibicui; Ibirapua; Itabela;
Itabuna; Itagimirim; Itaju do Colonia; Itajuipe; Itamaraju; Itambe;
Itanhem; Itape; Itapebi; Itapetinga; Itapitanga; Itarantim; Itororo;
Jucurusu; Jussari; Lajedao; Macarani; Maiquinique; Mascote; Medeiros
Neto; Nova Canaa; Pau Brasil; Piripa; Planalto; Posoes; Potiragua;
Ribeirao do Largo; Santa Cruz da Vitoria; Santa Luzia; São Jose da
Vitoria; Teixeira de Freitas; Tremedal; Vereda; Vitoria da Conquista;
- Espírito Santo State: at risk for yellow fever transmission with
the exception of the urban area of Vitoria;
- Rio de Janeiro State: at risk for yellow fever transmission in the
following northern municipalities bordering Minas Gerais and Espírito
Santo States: Bom Jesus do Itabapoana; Cambuci; Cardoso Moreira;
Italva; Itaperuna; Laje do Muriae; Miracema; Natividade; Porciuncula;
Santo Antonio de Padua; São Fidelis; São Jose de Uba; Varre-Sai;
Campos dos Goytacazes; São Francisco de Itabapoa; São João da
Barra.
This determination of new areas deemed to be at risk for yellow fever
transmission represents the first preliminary and precautionary step
of a dynamic risk assessment process.
WHO advice
----
Advice to travellers planning to visit areas at risk for yellow fever
transmission in Brazil includes vaccination against yellow fever at
least 10 days prior to the travel; observation of measures to avoid
mosquito bites, awareness of symptoms and signs of yellow fever,
promotion of health care seeking behavior while traveling and upon
return from an area at risk for yellow fever transmission, especially
to a country where the competent vector for yellow fever transmission
is present.
As per Annex 7 of the IHR a single dose of yellow fever vaccine is
sufficient to confer sustained immunity and life-long protection
against yellow fever disease. Booster doses of yellow fever vaccine
are not needed. If, on medical ground, a traveler cannot be vaccinated
against yellow fever, this must be certified by the relevant
authorities as per Annex 6 and Annex 7 of the IHR.
The WHO Secretariat does not recommend restriction of travel and trade
with Brazil on the basis of the information currently available on
this event.
[Veja o mapa acessando:
]
--
Comunicado por: ProMED-PORT
Comente essa matéria:
